| Association between high serum total cortisol concentrations and mortality from COVID-19 T Tan, B Khoo, EG Mills, M Phylactou, B Patel, PC Eng, L Thurston, ... The Lancet Diabetes & Endocrinology 8 (8), 659-660, 2020 | 272 | 2020 |
| Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia TM Tan, BCT Field, KA McCullough, RC Troke, ES Chambers, V Salem, ... Diabetes 62 (4), 1131-1138, 2013 | 252 | 2013 |
| Thyroid function before, during, and after COVID-19 B Khoo, T Tan, SA Clarke, EG Mills, B Patel, M Modi, M Phylactou, ... The Journal of Clinical Endocrinology & Metabolism 106 (2), e803-e811, 2021 | 232 | 2021 |
| The role of the gut/brain axis in modulating food intake AH Sam, RC Troke, TM Tan, GA Bewick Neuropharmacology 63 (1), 46-56, 2012 | 230 | 2012 |
| Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase NJ Beaumont, VO Skinner, TMM Tan, BS Ramesh, DJ Byrne, GS MacColl, ... Journal of Biological Chemistry 278 (11), 8877-8880, 2003 | 209 | 2003 |
| Targeting GLP-1 receptor trafficking to improve agonist efficacy B Jones, T Buenaventura, N Kanda, P Chabosseau, BM Owen, R Scott, ... Nature communications 9 (1), 1602, 2018 | 188 | 2018 |
| Glucagon increases energy expenditure independently of brown adipose tissue activation in humans V Salem, C Izzi‐Engbeaya, C Coello, DB Thomas, ES Chambers, ... Diabetes, Obesity and Metabolism 18 (1), 72-81, 2016 | 164 | 2016 |
| Minireview: glucagon in stress and energy homeostasis BJ Jones, T Tan, SR Bloom Endocrinology 153 (3), 1049-1054, 2012 | 159 | 2012 |
| Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intake J Cegla, RC Troke, B Jones, G Tharakan, J Kenkre, KA McCullough, ... Diabetes 63 (11), 3711-3720, 2014 | 156 | 2014 |
| Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome TMM Tan, M Vanderpump, B Khoo, M Patterson, MA Ghatei, ... The Journal of Clinical Endocrinology & Metabolism 89 (8), 4162-4165, 2004 | 153 | 2004 |
| The future role of gut hormones in the treatment of obesity RC Troke, TM Tan, SR Bloom Therapeutic advances in chronic disease 5 (1), 4-14, 2014 | 142 | 2014 |
| Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial AD Miras, B Pérez-Pevida, M Aldhwayan, A Kamocka, ER McGlone, ... The lancet Diabetes & endocrinology 7 (7), 549-559, 2019 | 122 | 2019 |
| A comparison of the performance of 68Ga-DOTATATE PET/CT and 123I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma JB Maurice, R Troke, Z Win, R Ramachandran, A Al-Nahhas, M Naji, ... European journal of nuclear medicine and molecular imaging 39, 1266-1270, 2012 | 117 | 2012 |
| The effects of kisspeptin on β‐cell function, serum metabolites and appetite in humans C Izzi‐Engbeaya, AN Comninos, SA Clarke, A Jomard, L Yang, S Jones, ... Diabetes, Obesity and Metabolism 20 (12), 2800-2810, 2018 | 104 | 2018 |
| 68Ga-DOTA-TATE PET vs. 123I-MIBG in Identifying Malignant Neural Crest Tumours M Naji, C Zhao, SJ Welsh, R Meades, Z Win, A Ferrarese, T Tan, ... Molecular Imaging and Biology 13, 769-775, 2011 | 104 | 2011 |
| Combined GLP-1, oxyntomodulin, and peptide YY improves body weight and glycemia in obesity and prediabetes/type 2 diabetes: a randomized, single-blinded, placebo-controlled study P Behary, G Tharakan, K Alexiadou, N Johnson, NJ Wewer Albrechtsen, ... Diabetes care 42 (8), 1446-1453, 2019 | 102 | 2019 |
| Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial KM Pollock, HM Cheeseman, AJ Szubert, V Libri, M Boffito, D Owen, ... EClinicalMedicine 44, 2022 | 101 | 2022 |
| The effect of a subcutaneous infusion of GLP-1, OXM, and PYY on energy intake and expenditure in obese volunteers T Tan, P Behary, G Tharakan, J Minnion, W Al-Najim, NJW Albrechtsen, ... The Journal of Clinical Endocrinology & Metabolism 102 (7), 2364-2372, 2017 | 100 | 2017 |
| Redefining the stress cortisol response to surgery B Khoo, PR Boshier, A Freethy, G Tharakan, S Saeed, N Hill, EL Williams, ... Clinical endocrinology 87 (5), 451-458, 2017 | 81 | 2017 |
| The obesity epidemic: pharmacological challenges SR Bloom, FP Kuhajda, I Laher, X Pi-Sunyer, GV Ronnett, TMM Tan, ... Molecular interventions 8 (2), 82, 2008 | 79 | 2008 |
Professor Waljit DhilloImperial College London在 imperial.ac.uk 的电子邮件经过验证
